Filter
453
Filtered Results: 453
Text search:
biomarkers
Featured
Recommendations
41
New Publications
99
Language
Document type
No document type
220
Studies & Reports
127
Guidelines
64
Manuals
14
Strategic & Response Plan
12
Fact sheets
7
Training Material
4
Situation Updates
2
Resource Platforms
2
Online Courses
1
Countries / Regions
India
50
Global
25
Africa
16
Kenya
10
Malawi
10
Russia
10
Western and Central Europe
9
Ghana
8
Nigeria
8
Germany
8
South Africa
8
Nepal
7
Zambia
7
Latin America and the Carribbean
6
Eastern Europe
6
Ethiopia
6
Ukraine
5
Sierra Leone
5
Zimbabwe
5
Asia
5
Tanzania
5
South–East Asia Region
5
Brazil
5
Lesotho
4
Rwanda
4
Uganda
4
Indonesia
4
Liberia
4
Myanmar / Burma
4
Philippines
3
Cambodia
3
Congo, Democratic Republic of
3
Bangladesh
3
Georgia
3
Burkina Faso
2
Middle East and North Africa
2
East and Southern Africa
2
Eswatini/ Swaziland
2
Pakistan
2
Tajikistan
1
Syria
1
Albania
1
Senegal
1
Estonia
1
Afghanistan
1
Mozambique
1
USA
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Portugal
1
Argentina
1
Sri Lanka
1
Namibia
1
Yemen
1
Romania
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
169
Clinical Guidelines
56
Public Health
30
Women & Child Health
14
Key Resources
11
Pharmacy & Technologies
7
Toolboxes
TB
46
HIV
36
Mental Health
35
NCDs
35
NTDs
27
COVID-19
26
AMR
17
Planetary Health
15
Caregiver
7
Rapid Response
6
Global Health Education
6
Refugee
3
Ebola
3
Specific Hazards
2
Pharmacy
2
Natural Hazards
1
Social Ethics
1
Health Financing Toolbox
1
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendati...
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health risks in their given health risk assessment contexts...
Guidelines for the Prevention and Contaiment of of Antimicrobial Resistance in South African Hospitals
recommended
These guidelines form part of efforts to institutionalize the prevention and containment of antimicrobial resistance (AMR) in healthcare facilities in South Africa, as outlined in the Antimicrobial Resistance Strategic Framework and Implementation Plan. The focus of these guidelines is on two interr...
This report presents the key findings of the NFHS-5 in West Bengal, followed by detailed tables and an appendix on sampling errors. At the time of finalization of this report, wealth quintiles for the country as a whole were not ready. Therefore, on finalization of the national report, the breakup o...
March 2021
This report presents the key findings of the NFHS-5 survey in Goa, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and eac...
March 2021
This report presents the key findings of the NFHS-5 survey in Maharashtra, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India...
March 2021
This report presents the key findings of the NFHS-5 survey in the National Capital Territory (NCT) of Delhi, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on populatio...
April 2021
This report presents the key findings of the NFHS-5 survey in Assam, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and e...
May 2021
This report presents the key findings of the NFHS-5 survey in Andhra Pradesh, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for Indi...
December 2022
This report presents the key findings of the NFHS-5 survey in Tamil Nadu, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for Ind...
May 2021
This report presents the key findings of the NFHS-5 survey in Telangana, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
Volume I, 2005-06
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
